Ola Wallerman
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Ophthalmology top 1%
- Glaucoma and retinal disorders
- Retinal Diseases and Treatments
Papers in
-
- Genomics and Chromatin Dynamics 7
- RNA Research and Splicing 5
- Genomics and Phylogenetic Studies 5
- RNA and protein synthesis mechanisms 3
- Genetics 13
- Genetic diversity and population structure 5
- Co-authors
- Claes Wadelius (19 shared papers)Mia Wadelius (5 shared papers)Håkan Melhus (2 shared papers)Mehdi Motallebipour (3 shared papers)Jilur Ghori (1 shared paper)D. R. Bentley (1 shared paper)Panos Deloukas (1 shared paper)Niclas Eriksson (1 shared paper)
- Journals
- Communications Biology (3 papers)Nucleic Acids Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Genome Research (2 papers)The Pharmacogenomics Journal (2 papers)
- Partner nations
- SwedenUnited StatesUnited Kingdom
In The Last Decade
Ola Wallerman
40 papers receiving 2.1k citations
Ola Wallerman's Hit Papers
Peers
Comparison fields: 5 of 104
- Pharmacology 398
- Ophthalmology 292
- Genetics 417
- Biochemistry 94
- Molecular Biology 706
Countries citing papers authored by Ola Wallerman
This map shows the geographic impact of Ola Wallerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ola Wallerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ola Wallerman more than expected).
Fields of papers citing papers by Ola Wallerman
This network shows the impact of papers produced by Ola Wallerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ola Wallerman. The network helps show where Ola Wallerman may publish in the future.
Co-authors
The 25 scholars most cited alongside Ola Wallerman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma Hit paper breakdown → | 2007 | 482 |
| 2 | 2005 | 372 | |
| 3 | 2003 | 159 | |
| 4 | 2005 | 99 | |
| 5 | 2021 | 88 | |
| 6 | 2019 | 82 | |
| 7 | 2005 | 64 | |
| 8 | 2009 | 57 | |
| 9 | 2009 | 56 | |
| 10 | 2021 | 51 | |
| 11 | 2018 | 46 | |
| 12 | 2021 | 38 | |
| 13 | 2017 | 37 | |
| 14 | 2022 | 36 | |
| 15 | 2016 | 36 | |
| 16 | 2011 | 33 | |
| 17 | 2007 | 31 | |
| 18 | 2015 | 28 | |
| 19 | 2019 | 27 | |
| 20 | 2020 | 25 |
About Ola Wallerman
Ola Wallerman is a scholar working on Molecular Biology, Genetics, Ecology, Evolution, Behavior and Systematics, Oncology and Plant Science, having authored 40 papers that have together received 2.1k indexed citations. Recurring topics across this work include Genomics and Chromatin Dynamics (7 papers), RNA Research and Splicing (5 papers), Genetic diversity and population structure (5 papers), Genomics and Phylogenetic Studies (5 papers), Drug Transport and Resistance Mechanisms (4 papers), Plant and animal studies (3 papers), Pancreatic function and diabetes (3 papers) and RNA and protein synthesis mechanisms (3 papers). The work is most often cited by research in Pharmacology (398 citations), Ophthalmology (292 citations), Genetics (417 citations), Biochemistry (94 citations) and Molecular Biology (706 citations). Ola Wallerman has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Claes Wadelius, Mia Wadelius, Håkan Melhus, Mehdi Motallebipour, Jilur Ghori, D. R. Bentley, Panos Deloukas, Niclas Eriksson, Sarah Hunt and Kate Downes. Their work appears in journals such as Communications Biology, Nucleic Acids Research, Proceedings of the National Academy of Sciences, Genome Research and The Pharmacogenomics Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.